Physician profile
Nicholas J Augustine
NPI 1164803102
$11,721.36
in general payments reported to CMS, 2019-2025
59 companies · $2,147 in 2025
The $2,147 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $875 · 2020: $1,117 · 2021: $2,250 · 2022: $1,917 · 2023: $1,638 · 2024: $1,777 · 2025: $2,147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,562.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,660.28 | 2020-2025 | Ubrelvy, Linzess, Viberzi |
| Astrazeneca Pharmaceuticals LP | $1,000.40 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $931.47 | 2019-2025 | |
| Novo Nordisk INC | $726.96 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $661.51 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Teva Pharmaceuticals USA, INC. | $629.76 | 2019-2024 | Austedo Xr, Ajovy, Austedo |
| Glaxosmithkline, LLC. | $528.65 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Amarin Pharma, INC. | $482.34 | 2019-2022 | |
| Astellas Pharma US INC | $410.29 | 2019-2025 | Veozah, Myrbetriq |
| Novartis Pharmaceuticals Corporation | $403.35 | 2020-2025 | |
| Amgen INC. | $394.76 | 2019-2025 | Repatha, Otezla, Otezla |
| Takeda Pharmaceuticals U.S.A., INC. | $347.65 | 2019-2023 | Trintellix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $287.23 | 2022-2025 | Caplyta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $261.05 | 2019-2025 | Jardiance |
| Biohaven Pharmaceutical Holding Company LTD. | $257.02 | 2022 |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $197.94 | 2019-2025 | Spravato |
| Daiichi Sankyo INC. | $186.94 | 2022-2025 | Injectafer |
| Biohaven Pharmaceuticals, INC. | $185.83 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $180.45 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $149.82 | 2021-2025 | Verquvo, Belsomra, Steglatro |
| Exact Sciences Corporation | $149.03 | 2023-2025 | Cologuard Collection Kit |
| Allergan, INC. | $113.38 | 2020 | |
| Sanofi-Aventis U.S. LLC | $107.66 | 2019-2025 | |
| Insulet Corporation | $104.67 | 2019-2025 | Omnipod |
| Esperion Therapeutics, INC. | $92.53 | 2020-2025 | Nexletol |
| Idorsia Pharmaceuticals US INC | $82.22 | 2022-2023 | Quviviq |
| Almatica Pharma LLC | $79.95 | 2021-2022 | |
| Biogen, INC. | $75.10 | 2025 | Zurzuvae |
| Amphastar Pharmaceuticals, INC. | $72.04 | 2025 | |
| Ucb, INC. | $68.46 | 2022-2024 | Rystiggo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.00 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $60.45 | 2025 | Rexulti |
| Mannkind Corporation | $50.97 | 2019 | |
| Eisai INC. | $50.28 | 2021-2025 | |
| Corcept Therapeutics | $48.28 | 2025 | Korlym |
| Ibsa Pharma INC. | $46.37 | 2020-2024 | Licart, Tirosint |
| Corium, LLC | $43.42 | 2023-2025 | Azstarys |
| Shield Therapeutics INC | $42.41 | 2023 | Accrufer |
| Arbor Pharmaceuticals, INC. | $42.32 | 2019-2021 | |
| Seqirus USA INC | $41.92 | 2023-2025 | Flucelvax Quadrivalent, Fluad Quadrivalent, Flucelvax |
| Neurocrine Biosciences, INC. | $37.00 | 2024-2025 | Ingrezza |
| Axsome Therapeutics, INC. | $36.32 | 2025 | Auvelity |
| Kowa Pharmaceuticals America, INC. | $34.89 | 2021-2022 | |
| Boston Scientific Corporation | $34.69 | 2025 | Watchman |
| Genentech USA, INC. | $31.20 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $27.05 | 2023 | Belbuca, Xtampza |
| Ardelyx, INC. | $26.84 | 2024 | Ibsrela |
| Abbott Laboratories | $21.50 | 2025 | Freestyle Libre 3 |
| Clarus Therapeutics INC. | $21.44 | 2021 | |
| Axonics, INC. | $19.12 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $15.58 | 2025 | Dupixent |
| Amneal Pharmaceuticals LLC | $14.67 | 2025 | Unithroid |
| Vertex Pharmaceuticals Incorporated | $14.20 | 2025 | |
| Nestle Healthcare Nutrition INC. | $13.00 | 2020 | |
| Cequr Corporation | $12.56 | 2025 | Cequr Simplicity |
| Assertio Therapeutics, INC. | $12.10 | 2020 | |
| Phathom Pharmaceuticals, INC. | $11.86 | 2025 | Voquezna |
| Gilead Sciences, INC. | $11.00 | 2020 | |
| Neuronetics, INC. | $9.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Augustine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.